MCID: GST009
MIFTS: 43

Gastroschisis malady

Categories: Rare diseases, Gastrointestinal diseases

Aliases & Classifications for Gastroschisis

About this section

Aliases & Descriptions for Gastroschisis:

Name: Gastroschisis 11 47 49 38 13 67
Congenital Fissure of the Abdominal Cavity 47
 
Laparoschisis 47

Classifications:



External Ids:

Disease Ontology11 DOID:11044
ICD1029 Q79.3
ICD9CM31 756.73
SNOMED-CT61 72951007
MeSH38 D020139
NCIt44 C84725

Summaries for Gastroschisis

About this section
Wikipedia:70 Gastroschisis represents a congenital defect characterised by a defect in the anterior abdominal wall... more...

MalaCards based summary: Gastroschisis, also known as congenital fissure of the abdominal cavity, is related to gastroschisis abdominal wall defects, included and abdominal wall defect. An important gene associated with Gastroschisis is AEBP1 (AE Binding Protein 1), and among its related pathways are IL-9 Signaling Pathways and their Primary Biological Effects in Different Immune Cell Types and Malaria. Affiliated tissues include skin, liver and small intestine, and related mouse phenotype homeostasis/metabolism.

Related Diseases for Gastroschisis

About this section

Diseases related to Gastroschisis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 97)
idRelated DiseaseScoreTop Affiliating Genes
1gastroschisis abdominal wall defects, included12.3
2abdominal wall defect11.8
3paraomphalocele10.8
4omphalocele10.6
5prostate leiomyosarcoma10.3IL6, MMP3
6bladder neck cancer10.2IL6, NPPA
7keloids10.2IL6, MMP3
8intestinal atresia10.1
9orbital periostitis10.1IL6, MMP3
10birth defects10.1
11vertebral artery occlusion10.0IL6, MMP3
12corneal intraepithelial neoplasm10.0IL6, MMP8
13neonatal period electroclinical syndrome10.0IL6, MMP8
14sternum lymphoma9.9IL6, MMP3
15actinomycosis9.9IL6, MMP1
16small intestine cancer, childhood9.9MMP1, MMP3
17congenital diaphragmatic hernia9.9
18pathological gambling9.9MMP1, MMP3
19juvenile astrocytoma9.9MMP1, MMP3
20nervous system cancer9.9IL6, MMP8
21retinal degeneration9.8MMP1, MMP3
22short bowel syndrome9.8
23secondary corneal edema9.8MMP1, MMP3
24bardet-biedl syndrome 89.8IL6, MMP1
25salt and pepper syndrome9.8MMP1, MMP3
26pneumoconiosis9.8MMP1, MMP3
27gallbladder lymphoma9.8MMP1, MMP3
28jejunal atresia9.8
29esophagitis9.8
30oligohydramnios9.8
31corpus callosum dysgenesis cleft spasm9.8MMP1, MMP3
32optic atrophy 79.8MMP1, MMP8
33chorioretinitis9.8IL6, MMP3, MMP8
34steroid-induced glaucoma9.8MMP1, MMP3
35mastoiditis9.7IL6, MMP1
36neural tube defects9.7
37prune belly syndrome9.7
38cryptorchidism9.7
39colonic atresia9.7
40craniosynostosis9.7
41orofacial cleft9.7
42gastric dilatation9.7
43ischemia9.7
44neuronitis9.7
45familial nephrotic syndrome9.6BMP1, MMP1, MMP3
46herpetic gastritis9.6MMP1, NPPA, TGFB3
47melorheostosis9.6IL6, MMP1, MMP3
48eosinophilic gastroenteritis9.6IL6, MMP8
49granulomatous orchitis9.6IL6, MMP1, MMP3
50malignant giant cell tumor9.6IL6, MMP1, MMP3

Graphical network of the top 20 diseases related to Gastroschisis:



Diseases related to gastroschisis

Symptoms for Gastroschisis

About this section

Drugs & Therapeutics for Gastroschisis

About this section

Drugs for Gastroschisis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Metoclopramideapproved, investigationalPhase 3116364-62-54168
Synonyms:
(metaclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
(metoclopramide)4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
1,5-Dimethyl-2-phenyl-1,2-dihydro-pyrazol-3-one
2-Methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-Methoxy-4-amino-5-chloro-N,N-dimethylaminoethyl)benzamide
2-Methoxy-5-chloroprocainamide
2-methoxy-4-amino-5-chloro-N,N-(dimethylaminoethyl)benzamide
2-methoxy-5-chloroprocainamide
2576-84-3 (di-hydrochloride)
364-62-5
4 Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-2-methoxy-N-(beta-diethylaminoethyl)benzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-o-anisamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (Mcp)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide (metoclopramide)
4-Amino-5-chloro-N-(2-diethylamino-ethyl)-2-methoxy-benzamide(Metoclopramide)
4-amino-5-chloro-2-Methoxy-N-(beta-diethylaminoethyl)benzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-2-methoxybenzamide
4-amino-5-chloro-N-(2-(Diethylamino)ethyl)-O-anisamide
4-amino-5-chloro-N-(2-diethylaminoethyl)-2-methoxybenzamide
4-amino-5-chloro-N-[2-(diethylamino)ethyl]-2-methoxybenzamide
5-Chloro-2-methoxyprocainamide
54143-57-6 (mono-hydrochloride, mono-hydrate)
7232-21-5 (mono-hydrochloride)
AB00053498
AC1L1HKD
AKOS000280832
ARONIS24307
Apo-Metoclop
BPBio1_000217
BPBio1_001100
BRD-K75641298-001-01-5
BRD-K75641298-003-05-2
BRN 1884366
BSPBio_000197
BSPBio_002027
Benzamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxy- (9CI)
Biomol-NT_000082
C07868
C14H22ClN3O2
CAS-7232-21-5
CHEBI:107736
CHEMBL86
CID4168
CLOPRA-"YELLOW"
Cerucal
Clopra
Clopra-Yellow
Clopromate
D00726
DB01233
DEL
DEL 1267
DivK1c_000069
Duraclamid
EINECS 206-662-9
Elieten
Elieten (TN)
Emetid
Emitasol
Emperal
Eucil
Gastrese
Gastro-Timelets
Gastrobid
Gastromax
Gastronerton
Gastrosil
Gastrotablinen
Gastrotem
HMS2089G16
IDI1_000069
Imperan
KBio1_000069
KBio2_002118
 
KBio2_004686
KBio2_007254
KBio3_001527
KBioGR_001307
KBioSS_002118
L001078
LS-20038
Lopac-M-0763
Lopac0_000762
Maxeran
Maxolon
Meclopran
Metaclopramide
Metaclopromide
Metamide
Methochlopramide
Methoclopramide
Metochlopramide
Metoclol
Metoclopramida
Metoclopramida [INN-Spanish]
Metoclopramide (JP15/INN)
Metoclopramide Hcl
Metoclopramide Hydrochloride
Metoclopramide Intensol
Metoclopramide Monohydrochloride, Monohydrate
Metoclopramide Omega
Metoclopramide [INN:BAN:JAN]
Metoclopramidum
Metoclopramidum [INN-Latin]
Metocobil
Metramid
MolPort-000-883-854
Moriperan
Mygdalon
N-(Diethylaminoethyl)-2-methoxy-4-amino-5-chlorobenzamide
NCGC00015643-01
NCGC00015643-02
NCGC00015643-03
NCGC00015643-08
NCGC00024440-03
NCGC00024440-04
NCI60_003185
NINDS_000069
Neu-Sensamide
Nu-Metoclopramide
Octamide
Parmid
Paspertin
Peraprin
Plasil
Plasil (pharmaceutical)
Pms-Metoclopramide
Pramidin
Pramiel
Pramin
Prestwick0_000209
Prestwick1_000209
Prestwick2_000209
Prestwick3_000209
Primperan
Reclomide
Reglan
Reliveran
SPBio_001740
SPBio_002118
ST024773
Spectrum2_001720
Spectrum3_000504
Spectrum4_000964
Spectrum5_001449
Spectrum_001638
Terperan
Terperan (TN)
UNII-L4YEB44I46
bmse000779
metoclopramide
o-Anisamide, 4-amino-5-chloro-N-(2-(diethylamino)ethyl)- (8CI)
2
DopamineapprovedPhase 3375951-61-6, 62-31-7681
Synonyms:
(3H)-Dopamine
.Beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
2-(3,4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl)ethylamine
2-benzenediol
3,4-Dihydroxyphenethylamine
3,4-Dihydroxyphenethylamine hydrochloride
3,4-Dihydroxyphenylethylamine
3,4-dihydroxyphenethylamine
3-Hydroxtyramine
3-Hydroxytyramine
3-Hydroxytyramine Hydrobromide
3-Hydroxytyramine hydrochloride
4-(2-Aminoethyl)-1,
4-(2-Aminoethyl)-1,2-benzenediol
4-(2-Aminoethyl)-1,2-bezenediol
4-(2-Aminoethyl)-Pyrocatechol
4-(2-Aminoethyl)benzene-1,2-diol
4-(2-Aminoethyl)catechol
4-(2-Aminoethyl)pyrocatechol
4-(2-Aminoethyl)pyrocatechol hydrochloride
4-(2-aminoethyl)-pyrocatechol
50444-17-2
51-61-6
62-31-7 (HYDROCHLORIDE)
AC1L19S5
AC1Q54AX
AC1Q54AY
AKOS003790978
ASL 279
BIDD:ER0506
BPBio1_001123
BSPBio_001932
Biomol-NT_000001
C03758
CHEBI:18243
CHEMBL59
CID681
D07870
DB00988
Deoxyepinephrine
DivK1c_000780
Dopamin
Dopamina
Dopamina [INN-Spanish]
Dopamine
Dopamine (INN)
Dopamine (USAN)(*hydrochloride*)
Dopamine [INN:BAN]
Dopaminum
Dopaminum [INN-Latin]
Dopastat
Dophamine
Dynatra
EINECS 200-110-0
HSDB 3068
Hydroxytyramin
Hydroxytyramine
IDI1_000780
IP 498
Intropin
Intropin [*hydrochloride*]
KBio1_000780
 
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
KW-3-060
L-DOPAMINE
L000232
LDP
LS-159
Lopac-H-8502
Lopac0_000586
Medopa (TN)
MolPort-001-641-000
NCGC00015519-01
NCGC00015519-08
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
NINDS_000780
NSC 173182
NSC169105
NSC173182
Oprea1_088821
Oxytyramine
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
Revimine
Revivan
SPBio_001205
SPECTRUM1505155
ST048774
STK301601
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Spectrum_001012
UNII-VTD58H1Z2X
UPCMLD0ENAT5885989:001
a-(3,4-Dihydroxyphenyl)-b-aminoethane
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
cMAP_000036
cMAP_000065
dopamine
hydroxytyramine
intropin
m-Hydroxytyramine hydrochloride
nchembio.105-comp9
nchembio.107-comp4
nchembio.284-comp1
nchembio.78-comp16
nchembio.89-comp3
nchembio705-8
nchembio801-comp8
3Peripheral Nervous System AgentsPhase 322776
4Neurotransmitter AgentsPhase 317734
5AntiemeticsPhase 33888
6Gastrointestinal AgentsPhase 3, Phase 1, Phase 28109
7Dopamine D2 Receptor AntagonistsPhase 3332
8Dopamine AgentsPhase 33759
9Autonomic AgentsPhase 39774
10Dopamine AntagonistsPhase 31083
11Pharmaceutical SolutionsPhase 27793
12Soybean oil, phospholipid emulsionPhase 273
13Protective AgentsPhase 27190
14Parenteral Nutrition SolutionsPhase 2153
15AntioxidantsPhase 22928
16Fat Emulsions, IntravenousPhase 292
17
BilirubinPhase 2112635-65-45280352
Synonyms:
(4Z,15Z)-Bilirubin IXa
(Z,Z)-Bilirubin IXa
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionate
1,10,19,22,23,24-Hexahydro-2,7,13,17-tetramethyl-1,19-dioxo-3,18-divinyl-Biline-8,12-dipropionic acid
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoate
2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-Biline-8,12-dipropanoic acid
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoate
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-((3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-2-yl)methyl)-4-methyl-5-((4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
 
3-(2-((3-(2-Carboxyethyl)-4-methyl-5-[(Z)-(3-methyl-5-oxo-4-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene)methyl]-1H-pyrrol-2-yl)methyl)-4-methyl-5-[(Z)-(4-methyl-5-oxo-3-vinyl-1,5-dihydro-2H-pyrrol-2-ylidene
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoate
3-[2-[[3-(2-Carboxyethyl)-5-[(Z)-(3-ethenyl-4-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(4-ethenyl-3-methyl-5-oxo-pyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoic acid
Bilirubin
Bilirubin IX-alpha
Cholerythrin
Hematoidin
18Liver ExtractsPhase 23868
19Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 1, Phase 212767
20IncretinsPhase 1, Phase 21537
21HormonesPhase 1, Phase 213979
22Hormone AntagonistsPhase 1, Phase 212778
23glucagonPhase 1, Phase 2462
24Glucagon-Like Peptide 1Phase 1, Phase 2694
25Omega 3 Fatty AcidNutraceuticalPhase 2969
26Soy BeanNutraceuticalPhase 2535
27Micronutrients5802
28Vitamins5095
29Trace Elements5802
30BifidobacteriumNutraceutical230
31lysineNutraceutical90

Interventional clinical trials:

(show all 17)
idNameStatusNCT IDPhase
1Trial of AMNIOECHANGE in Gastroschisis Affected FoetusesUnknown statusNCT00127946Phase 3
2Metoclopramide Pilot TrialRecruitingNCT02098915Phase 3
3Randomized Clinical Trial of Early Delivery in Fetal Gastroschisis vs. Routine CareActive, not recruitingNCT01884324Phase 2, Phase 3
4Evaluating the Use of a Silastic Spring-Loaded Silo for Infants With GastroschisisCompletedNCT00539292Phase 2
5Compassionate Use of Omegaven in ChildrenRecruitingNCT02370251Phase 2
6Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal FailureTerminatedNCT01573286Phase 1, Phase 2
7Sutureless vs Sutured Gastroschisis ClosureUnknown statusNCT01094587
8Music Therapy: An Adjunct To Gastroschisis Infants' CareUnknown statusNCT01469208
9Probiotics in Infants With GastroschisisUnknown statusNCT01316510
10Elemental Formula in Neonates Post Small Bowel Resection: Improved Weaning From Total Parenteral Nutrition?Unknown statusNCT01891279
11PREMAPIV : Intravesical Pressure Variation at Different Bladder Instillation Volumes in Newborn ChildrenCompletedNCT01296724
12Determination of Lysine Requirement in the Parenterally Fed NeonateCompletedNCT00779753
13Silo Versus Primary Closure for GastroschisisRecruitingNCT01506531
14Clinical and Biological Outcomes of Human Milk and Formula Intake After Gastroschisis RepairRecruitingNCT02575846
15Gastroschisis Outcomes of Delivery (GOOD) StudyNot yet recruitingNCT02774746
16Bedside Silo Versus Operative Closure for GastroschisisTerminatedNCT00404690
17Prevention of Parenteral Nutrition-Associated Cholestasis With Cyclic Parenteral Nutrition in InfantsTerminatedNCT01062815

Search NIH Clinical Center for Gastroschisis


Cochrane evidence based reviews: gastroschisis

Genetic Tests for Gastroschisis

About this section

Anatomical Context for Gastroschisis

About this section

MalaCards organs/tissues related to Gastroschisis:

35
Skin, Liver, Small intestine, Colon, Heart, Smooth muscle, Testis

Animal Models for Gastroschisis or affiliated genes

About this section

MGI Mouse Phenotypes related to Gastroschisis:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053765.8ACHE, ADD1, AEBP1, BMP1, IL6, MMP1

Publications for Gastroschisis

About this section

Articles related to Gastroschisis:

(show top 50)    (show all 720)
idTitleAuthorsYear
1
Closed gastroschisis, vanishing midgut and extreme short bowel syndrome: Case report and review of the literature. (27867410)
2016
2
Oligohydramnios and growth restriction do not portend worse prognosis in gastroschisis pregnancies. (26932657)
2016
3
Gastroschisis with Concomitant Jejuno-Ileal Atresia Complicated by Jejunal Perforation. (27123409)
2016
4
Gastroschisis outcomes in North America: a comparison of Canada and the United States. (27004440)
2016
5
Management and outcome challenges in newborns with gastroschisis: A 6-year retrospective French study. (27892784)
2016
6
Gene variants as risk factors for gastroschisis. (27616475)
2016
7
Feeding Intolerance and Poor Growth in Infants with Gastroschisis: Longitudinal Experience with Consecutive Patients over Thirteen Years. (26500852)
2015
8
The long-term neurodevelopmental and psychological outcomes of gastroschisis: A cohort study. (26490011)
2015
9
Prenatal examination and postmortem findings in fetuses with gastroschisis and omphalocele. (24604302)
2014
10
Prevalence and risk factors for gastroschisis in a public hospital from west MAcxico. (25243388)
2014
11
Gastroschisis, omphalocele or something else? (23531629)
2014
12
Left-sided Gastroschisis: A Rare Congenital Anomaly. (24298510)
2013
13
Human milk versus formula after gastroschisis repair: effects on time to full feeds and time to discharge. (23519369)
2013
14
Expectant management compared with elective delivery at 37 weeks for gastroschisis. (23635735)
2013
15
Gastroschisis, destructive brain lesions, and placental infarction in the second trimester suggest a vascular pathogenesis. (23895144)
2013
16
Left-sided gastroschisis with placenta findings: case report and literature review. (22558479)
2012
17
Gastroschisis: a multi-centre comparison of management and outcome. (22382099)
2012
18
Gastroschisis with ceco-appendicular agenesis: a novel presentation. (22925221)
2012
19
Ultrasound prediction of birthweight and growth restriction in fetal gastroschisis. (20723876)
2010
20
Changes in amniotic fluid index after maternal oral hydration in pregnancies with fetal gastroschisis: initial observations. (20606383)
2010
21
Evisceration and necrosis of gall bladder and evisceration of urinary bladder in a patient of gastroschisis. (20098013)
2010
22
Benchmarking the quality of care of infants with low-risk gastroschisis using a novel risk stratification index. (20236674)
2010
23
Perinatal demography of gastroschisis in North Queensland. (21166913)
2010
24
Gastroschisis and intrauterine growth restriction. (20362958)
2010
25
Mirror image left-sided gastroschisis. (20618216)
2010
26
Gastroschisis associated with an intra-abdominal umbilical vein varix: a report of 2 cases. (19786788)
2009
27
Spontaneous sutureless closure of the abdominal wall defect in gastroschisis using a commercial wound retractor system. (19705131)
2009
28
Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis? (19533769)
2009
29
Rare case of fetal gastroschisis with aplasia of the foot and external genital organs. (18778459)
2008
30
Novel intra-operative pulse oximetry monitoring for gastroschisis: a noninvasive monitor of intra-abdominal pressure. (18315652)
2008
31
Fetal abdominal wall repair with a collagen biomatrix in an experimental sheep model for gastroschisis. (18636946)
2008
32
Scheduled preterm delivery for gastroschisis improves postoperative outcome. (18668252)
2008
33
Non-genetic risk factors for gastroschisis. (18655102)
2008
34
Ruptured omphalocele with extracorporeal intestines mimicking gastroschisis in a fetus with Turner syndrome. (17694577)
2007
35
Outcomes of pregnancies with fetal gastroschisis. (17766615)
2007
36
Anesthesia for repair of gastroschisis in thoracopagus twins: a case report. (17263745)
2007
37
Does gastroschisis reduction require general anesthesia? A comparative analysis. (16818066)
2006
38
Fetal home monitoring for the prenatal management of gastroschisis. (15488122)
2004
39
Isolated gastroschisis in successive siblings: a case report and review of the literature. (15193205)
2004
40
The effect on the intestines of continuous release of methylene blue from a drug delivery system: an experimental study in a chick embryo gastroschisis model. (15338173)
2004
41
Unusual presentations of gastroschisis. (12206609)
2002
42
The outcome and analysis of 40 cases of fetal gastroschisis. (12370717)
2002
43
Effects of amnio-allantoic fluid exchange on bowel contractility in chick embryos with gastroschisis. (12407545)
2002
44
An unusual case of gastroschisis with gallbladder evisceration and late postrepair chylous ascites. (9434035)
1997
45
Omphalocele and gastroschisis in Europe: a survey of 3 million births 1980-1990. EUROCAT Working Group. (8533813)
1995
46
Abdominal wall defects: omphalocele and gastroschisis (continuing education credit). (2961975)
1987
47
Omphalocele, hernia of the umbilical cord and gastroschisis. (6232916)
1983
48
Congenital abdominal wall defects: gastroschisis and omphalocele. (6211335)
1982
49
Immediate permanent fascial prosthesis for gastroschisis and massive omphalocele. (6454268)
1981
50
Perinatal aspects of omphalocele and gastroschisis. (930890)
1977

Variations for Gastroschisis

About this section

Expression for genes affiliated with Gastroschisis

About this section
Search GEO for disease gene expression data for Gastroschisis.

Pathways for genes affiliated with Gastroschisis

About this section

GO Terms for genes affiliated with Gastroschisis

About this section

Cellular components related to Gastroschisis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1proteinaceous extracellular matrixGO:00055788.3BMP1, MMP1, MMP3, MMP8
2extracellular spaceGO:00056156.6ACHE, AEBP1, BMP1, IL6, MMP3, MMP8
3extracellular regionGO:00055766.1ACHE, BMP1, IL6, MMP1, MMP3, MMP8

Biological processes related to Gastroschisis according to GeneCards Suite gene sharing:

(show all 9)
idNameGO IDScoreTop Affiliating Genes
1positive regulation of pathway-restricted SMAD protein phosphorylationGO:001086210.2BMP1, TGFB3
2positive regulation of DNA replicationGO:004574010.0IL6, TGFB3
3positive regulation of protein oligomerizationGO:00324619.9MMP1, MMP3
4positive regulation of protein secretionGO:00507149.8ACHE, TGFB3
5regulation of MAPK cascadeGO:00434089.7BMP1, TGFB3
6regulation of apoptotic processGO:00429819.6BMP1, IL6, TGFB3
7collagen catabolic processGO:00305748.9MMP1, MMP3, MMP8
8extracellular matrix disassemblyGO:00226178.5BMP1, MMP1, MMP3, MMP8
9proteolysisGO:00065087.9BMP1, MMP1, MMP3, MMP8

Molecular functions related to Gastroschisis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytokine activityGO:00051259.8BMP1, IL6, TGFB3
2growth factor activityGO:00080839.8BMP1, IL6, TGFB3
3metalloendopeptidase activityGO:00042228.6BMP1, MMP1, MMP3, MMP8
4serine-type endopeptidase activityGO:00042528.2BMP1, MMP1, MMP3, MMP8
5calcium ion bindingGO:00055098.2BMP1, MMP1, MMP3, MMP8
6zinc ion bindingGO:00082707.8AEBP1, BMP1, MMP1, MMP3, MMP8

Sources for Gastroschisis

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet